{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T17:01:35Z","timestamp":1784653295027,"version":"3.55.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,21]]},"DOI":"10.7759\/cureus.113105","type":"journal-article","created":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T16:04:09Z","timestamp":1784649849000},"source":"Crossref","is-referenced-by-count":0,"title":["DEXA-Derived Body Fat Distribution and Its Correlation With Clinical, Anthropometric, Insulin Sensitivity, Metabolic, and Hormonal Parameters Among Kashmiri Polyendocrine Metabolic Ovarian Syndrome (PMOS) Women: A Cross-Sectional Study"],"prefix":"10.7759","author":[{"given":"Syed Douhath","family":"Yousuf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waseem","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajaz","family":"Qadir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nafeez u","family":"Rehman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid u","family":"Islam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohd Ashraf","family":"Ganie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1210\/js.2019-00078","article-title":"Polycystic ovary syndrome: pathophysiology, presentation, and treatment with emphasis on adolescent girls","volume":"3","author":"Witchel SF","year":"2019","unstructured":"Witchel SF, Oberfield SE, Pe\u00f1a AS. Polycystic ovary syndrome: pathophysiology, presentation, and treatment with emphasis on adolescent girls. J Endocr Soc. 2019, 3:1545-73. 10.1210\/js.2019-00078","journal-title":"J Endocr Soc"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3390\/nu13113925","article-title":"Metabolically healthy obesity (MHO) vs. metabolically unhealthy obesity (MUO) phenotypes in PCOS: association with endocrine-metabolic profile, adherence to the Mediterranean diet, and body composition","volume":"13","author":"Barrea L","year":"2021","unstructured":"Barrea L, Muscogiuri G, Pugliese G, de Alteriis G, Colao A, Savastano S. Metabolically healthy obesity (MHO) vs. metabolically unhealthy obesity (MUO) phenotypes in PCOS: association with endocrine-metabolic profile, adherence to the Mediterranean diet, and body composition. Nutrients. 2021, 13:3925. 10.3390\/nu13113925","journal-title":"Nutrients"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.2741\/e695","article-title":"Polycystic ovary syndrome: current status and future perspective","volume":"6","author":"Barthelmess EK","year":"2014","unstructured":"Barthelmess EK, Naz RK. Polycystic ovary syndrome: current status and future perspective. Front Biosci (Elite Ed). 2014, 6:104-19. 10.2741\/e695","journal-title":"Front Biosci (Elite Ed)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/719050","article-title":"Polycystic ovary syndrome, insulin resistance, and obesity: navigating the pathophysiologic labyrinth","volume":"2014","author":"Rojas J","year":"2014","unstructured":"Rojas J, Ch\u00e1vez M, Olivar L, et al.. Polycystic ovary syndrome, insulin resistance, and obesity: navigating the pathophysiologic labyrinth. Int J Reprod Med. 2014, 2014:719050. 10.1155\/2014\/719050","journal-title":"Int J Reprod Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1159\/000345310","article-title":"Development of obesity and polycystic ovary syndrome in adolescents","volume":"78","author":"Vilmann LS","year":"2012","unstructured":"Vilmann LS, Thisted E, Baker JL, Holm JC. Development of obesity and polycystic ovary syndrome in adolescents. Horm Res Paediatr. 2012, 78:269-78. 10.1159\/000345310","journal-title":"Horm Res Paediatr"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1177\/1179558119874042","article-title":"Obesity and polycystic ovary syndrome: implications for pathogenesis and novel management strategies","volume":"13","author":"Barber TM","year":"2019","unstructured":"Barber TM, Hanson P, Weickert MO, Franks S. Obesity and polycystic ovary syndrome: implications for pathogenesis and novel management strategies. Clin Med Insights Reprod Health. 2019, 13:1179558119874042. 10.1177\/1179558119874042","journal-title":"Clin Med Insights Reprod Health"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-022-03030-x","article-title":"Body mass index (BMI), waist circumference (WC), waist-to-height ratio (WHtR) e waist body mass index (wBMI): which is better?","volume":"76","author":"Moltrer M","year":"2022","unstructured":"Moltrer M, Pala L, Cosentino C, Mannucci E, Rotella CM, Cresci B. Body mass index (BMI), waist circumference (WC), waist-to-height ratio (WHtR) e waist body mass index (wBMI): which is better?. Endocrine. 2022, 76:578-83. 10.1007\/s12020-022-03030-x","journal-title":"Endocrine"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2007.09.001","article-title":"Androgens and body fat distribution","volume":"108","author":"Blouin K","year":"2008","unstructured":"Blouin K, Boivin A, Tchernof A. Androgens and body fat distribution. J Steroid Biochem Mol Biol. 2008, 108:272-80. 10.1016\/j.jsbmb.2007.09.001","journal-title":"J Steroid Biochem Mol Biol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9030732","article-title":"Body composition, serum concentrations of androgens and insulin resistance in different polycystic ovary syndrome phenotypes","volume":"9","author":"Polak AM","year":"2020","unstructured":"Polak AM, Adamska A, Krentowska A, \u0141ebkowska A, Hryniewicka J, Adamski M, Kowalska I. Body composition, serum concentrations of androgens and insulin resistance in different polycystic ovary syndrome phenotypes. J Clin Med. 2020, 9:732. 10.3390\/jcm9030732","journal-title":"J Clin Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/16.6.1255","article-title":"Body composition characteristics and body fat distribution in lean women with polycystic ovary syndrome","volume":"16","author":"Kirchengast S","year":"2001","unstructured":"Kirchengast S, Huber J. Body composition characteristics and body fat distribution in lean women with polycystic ovary syndrome. Hum Reprod. 2001, 16:1255-60. 10.1093\/humrep\/16.6.1255","journal-title":"Hum Reprod"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/NT.0000000000000092","article-title":"Body mass index: obesity, BMI, and health: a critical review","volume":"50","author":"Nuttall FQ","year":"2015","unstructured":"Nuttall FQ. Body mass index: obesity, BMI, and health: a critical review. Nutr Today. 2015, 50:117-28. 10.1097\/NT.0000000000000092","journal-title":"Nutr Today"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/9191505","article-title":"The use of SenseWear Armband for assessment of daily energy expenditure and the relation to body fat distribution and nutritional intake in lean women with polycystic ovary syndrome","volume":"2020","author":"Arusoglu G","year":"2020","unstructured":"Arusoglu G. The use of SenseWear Armband for assessment of daily energy expenditure and the relation to body fat distribution and nutritional intake in lean women with polycystic ovary syndrome. J Nutr Metab. 2020, 2020:9191505. 10.1155\/2020\/9191505","journal-title":"J Nutr Metab"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1152\/japplphysiol.01234.2003","article-title":"Validity and reliability of dual-energy X-ray absorptiometry for the assessment of abdominal adiposity","volume":"97","author":"Glickman SG","year":"2004","unstructured":"Glickman SG, Marn CS, Supiano MA, Dengel DR. Validity and reliability of dual-energy X-ray absorptiometry for the assessment of abdominal adiposity. J Appl Physiol (1985). 2004, 97:509-14. 10.1152\/japplphysiol.01234.2003","journal-title":"J Appl Physiol (1985)"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.2006.01008.x","article-title":"PCOS according to the Rotterdam consensus criteria: change in prevalence among WHO-II anovulation and association with metabolic factors","volume":"113","author":"Broekmans FJ","year":"2006","unstructured":"Broekmans FJ, Knauff EA, Valkenburg O, Laven JS, Eijkemans MJ, Fauser BC. PCOS according to the Rotterdam consensus criteria: change in prevalence among WHO-II anovulation and association with metabolic factors. BJOG. 2006, 113:1210-7. 10.1111\/j.1471-0528.2006.01008.x","journal-title":"BJOG"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-21-11-1440","article-title":"Clinical assessment of body hair growth in women","volume":"21","author":"Ferriman D","year":"1961","unstructured":"Ferriman D, Gallwey JD. Clinical assessment of body hair growth in women. J Clin Endocrinol Metab. 1961, 21:1440-7. 10.1210\/jcem-21-11-1440","journal-title":"J Clin Endocrinol Metab"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2019.01.015","article-title":"Diagnosis of disorders of glucose tolerance in women with polycystic ovary syndrome (PCOS) at a tertiary care center: fasting plasma glucose or oral glucose tolerance test?","volume":"93","author":"Ortiz-Flores AE","year":"2019","unstructured":"Ortiz-Flores AE, Luque-Ram\u00edrez M, Fern\u00e1ndez-Dur\u00e1n E, Alvarez-Blasco F, Escobar-Morreale HF. Diagnosis of disorders of glucose tolerance in women with polycystic ovary syndrome (PCOS) at a tertiary care center: fasting plasma glucose or oral glucose tolerance test?. Metabolism. 2019, 93:86-92. 10.1016\/j.metabol.2019.01.015","journal-title":"Metabolism"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and \u03b2-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews DR","year":"1985","unstructured":"Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and \u03b2-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985, 28:412-9. 10.1007\/BF00280883","journal-title":"Diabetologia"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.85.7.6661","article-title":"Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans","volume":"85","author":"Katz A","year":"2000","unstructured":"Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, Quon MJ. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab. 2000, 85:2402-10. 10.1210\/jcem.85.7.6661","journal-title":"J Clin Endocrinol Metab"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1080\/07853890500383895","article-title":"Is visceral obesity the cause of the metabolic syndrome?","volume":"38","author":"Despr\u00e9s JP","year":"2006","unstructured":"Despr\u00e9s JP. Is visceral obesity the cause of the metabolic syndrome?. Ann Med. 2006, 38:52-63. 10.1080\/07853890500383895","journal-title":"Ann Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1080\/13543784.2020.1781815","article-title":"Current and experimental drug therapy for the treatment of polycystic ovarian syndrome","volume":"29","author":"Della Corte L","year":"2020","unstructured":"Della Corte L, Foreste V, Barra F, et al.. Current and experimental drug therapy for the treatment of polycystic ovarian syndrome. Expert Opin Investig Drugs. 2020, 29:819-30. 10.1080\/13543784.2020.1781815","journal-title":"Expert Opin Investig Drugs"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1186\/s12944-015-0061-y","article-title":"Importance of lipid accumulation product index as a marker of CVD risk in PCOS women","volume":"14","author":"Nascimento JX","year":"2015","unstructured":"Nascimento JX, Chein MB, de Sousa RM, Ferreira Ados S, Navarro PA, Brito LM. Importance of lipid accumulation product index as a marker of CVD risk in PCOS women. Lipids Health Dis. 2015, 14:62. 10.1186\/s12944-015-0061-y","journal-title":"Lipids Health Dis"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-016-0582-x","article-title":"Visceral adiposity index levels in overweight and\/or obese, and non-obese patients with polycystic ovary syndrome and its relationship with metabolic and inflammatory parameters","volume":"40","author":"Durmus U","year":"2017","unstructured":"Durmus U, Duran C, Ecirli S. Visceral adiposity index levels in overweight and\/or obese, and non-obese patients with polycystic ovary syndrome and its relationship with metabolic and inflammatory parameters. J Endocrinol Invest. 2017, 40:487-97. 10.1007\/s40618-016-0582-x","journal-title":"J Endocrinol Invest"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-277X.2010.01130.x","article-title":"Upper trunk fat assessment and its relationship with metabolic and biochemical variables and body fat in polycystic ovary syndrome","volume":"24","author":"Penaforte FR","year":"2011","unstructured":"Penaforte FR, Japur CC, Diez-Garcia RW, Chiarello PG. Upper trunk fat assessment and its relationship with metabolic and biochemical variables and body fat in polycystic ovary syndrome. J Hum Nutr Diet. 2011, 24:39-46. 10.1111\/j.1365-277X.2010.01130.x","journal-title":"J Hum Nutr Diet"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.1085656","article-title":"Relationship between body composition, insulin resistance, and hormonal profiles in women with polycystic ovary syndrome","volume":"13","author":"Zhang H","year":"2022","unstructured":"Zhang H, Wang W, Zhao J, et al.. Relationship between body composition, insulin resistance, and hormonal profiles in women with polycystic ovary syndrome. Front Endocrinol (Lausanne). 2022, 13:1085656. 10.3389\/fendo.2022.1085656","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2016-2586","article-title":"Hyperandrogenism accompanies increased intra-abdominal fat storage in normal weight polycystic ovary syndrome women","volume":"101","author":"Dumesic DA","year":"2016","unstructured":"Dumesic DA, Akopians AL, Madrigal VK, et al.. Hyperandrogenism accompanies increased intra-abdominal fat storage in normal weight polycystic ovary syndrome women. J Clin Endocrinol Metab. 2016, 101:4178-88. 10.1210\/jc.2016-2586","journal-title":"J Clin Endocrinol Metab"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1055\/a-2386-9281","article-title":"Fat distribution and its correlation with insulin resistance, androgen markers, and proinflammatory cytokines in polycystic ovary syndrome","volume":"57","author":"de Melo Cavalcante RB","year":"2025","unstructured":"de Melo Cavalcante RB, Le\u00e3o LM, Tavares AB, Lopes KG, Kraemer-Aguiar LG. Fat distribution and its correlation with insulin resistance, androgen markers, and proinflammatory cytokines in polycystic ovary syndrome. Horm Metab Res. 2025, 57:25-32. 10.1055\/a-2386-9281","journal-title":"Horm Metab Res"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1111\/aogs.12706","article-title":"Polycystic ovary syndrome: cardiovascular risk factors according to specific phenotypes","volume":"94","author":"Aziz M","year":"2015","unstructured":"Aziz M, Sidelmann JJ, Faber J, et al.. Polycystic ovary syndrome: cardiovascular risk factors according to specific phenotypes. Acta Obstet Gynecol Scand. 2015, 94:1082-9. 10.1111\/aogs.12706","journal-title":"Acta Obstet Gynecol Scand"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.82.2.3722","article-title":"Effects of metformin on insulin secretion, insulin action, and ovarian steroidogenesis in women with polycystic ovary syndrome","volume":"82","author":"Ehrmann DA","year":"1997","unstructured":"Ehrmann DA, Cavaghan MK, Imperial J, Sturis J, Rosenfield RL, Polonsky KS. Effects of metformin on insulin secretion, insulin action, and ovarian steroidogenesis in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 1997, 82:524-30. 10.1210\/jcem.82.2.3722","journal-title":"J Clin Endocrinol Metab"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2005.11.012","article-title":"The association of serum androgens and insulin resistance with fat distribution in polycystic ovary syndrome","volume":"126","author":"Yucel A","year":"2006","unstructured":"Yucel A, Noyan V, Sagsoz N. The association of serum androgens and insulin resistance with fat distribution in polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol. 2006, 126:81-6. 10.1016\/j.ejogrb.2005.11.012","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.3390\/nu13124217","article-title":"Body composition and its impact on the hormonal disturbances in women with polycystic ovary syndrome","volume":"13","author":"Bizo\u0144 A","year":"2021","unstructured":"Bizo\u0144 A, P\u0142aczkowska S, Niepsuj J, et al.. Body composition and its impact on the hormonal disturbances in women with polycystic ovary syndrome. Nutrients. 2021, 13:4217. 10.3390\/nu13124217","journal-title":"Nutrients"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/492164-dexa-derived-body-fat-distribution-and-its-correlation-with-clinical-anthropometric-insulin-sensitivity-metabolic-and-hormonal-parameters-among-kashmiri-polyendocrine-metabolic-ovarian-syndrome-pmos-women-a-cross-sectional-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T16:04:10Z","timestamp":1784649850000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/492164-dexa-derived-body-fat-distribution-and-its-correlation-with-clinical-anthropometric-insulin-sensitivity-metabolic-and-hormonal-parameters-among-kashmiri-polyendocrine-metabolic-ovarian-syndrome-pmos-women-a-cross-sectional-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,21]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.113105","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7,21]]}}}